Neuroscience News logo for mobile.

How a Neurotransmitter May Be the Key in Controlling Alzheimer’s Toxicity​

Summary: Study reveals how somatostatin and copper affect amyloid beta in Alzheimer’s disease pathology. Source: KAIST With nearly 50 million dementia patients worldwide, and Alzheimers’s disease is the most common neurodegenerative disease. Its main symptom is the impairment of general cognitive abilities, including the ability to speak or to remember. The importance of finding a …

How a Neurotransmitter May Be the Key in Controlling Alzheimer’s Toxicity​ Read More »